You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemo treatment

Showing 1 - 25 of 2,488
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy Trial in México (Gemcitabine, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • +2 more
  • México, Ciudad De México, Mexico
    National Cancer Institute of Mexico
Nov 27, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

Active, not recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Jul 4, 2023

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Split-course hypo-CCRT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Aug 26, 2023

Cancer, Psychosocial Problem, Gastrointestinal Dysfunction Trial (Multistrain Probiotic, Placebo)

Not yet recruiting
  • Cancer
  • +2 more
  • Multistrain Probiotic
  • Placebo
  • (no location specified)
Oct 12, 2023

SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)

Recruiting
  • SCCHN
  • Squamous Cell Carcinoma
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 5, 2023

Dental Caries Trial in Alexandria (BRIX3000, papacarie, hand excavation)

Recruiting
  • Dental Caries
  • BRIX3000
  • +2 more
  • Alexandria, Egypt
    Faculty of Dentistry
Aug 7, 2023

Breast Cancer Trial (Intra-arterial chemoinfusion of breast cancer)

Not yet recruiting
  • Breast Cancer
  • Intra-arterial chemoinfusion of breast cancer
  • (no location specified)
Dec 14, 2022

Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)

Recruiting
  • Pancreatic Cancer
  • Sydney, New South Wales, Australia
  • +2 more
Oct 19, 2023

Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),

Not yet recruiting
  • Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
  • Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
  • +2 more
  • (no location specified)
Aug 16, 2022

Gynecologic Cancer Trial (MonaLisa Touch device, Vaginal dilatators)

Not yet recruiting
  • Gynecologic Cancer
  • MonaLisa Touch device
  • Vaginal dilatators
  • (no location specified)
Jun 5, 2023

Head Neck Cancer, Dysphagia Trial in Brussels (Acoustic cough features analysis)

Recruiting
  • Head and Neck Cancer
  • Dysphagia
  • Acoustic cough features analysis
  • Brussels, Belgium
    Institut Jules Bordet
May 9, 2023

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

Not yet recruiting
  • Breast Cancer Triple Negative
  • +3 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    May 18, 2023

    B-cell Non-Hodgkin's Lymphoma Trial (SHR-A1912; R-Chemo)

    Not yet recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • SHR-A1912; R-Chemo
    • (no location specified)
    Oct 23, 2023

    Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

    Not yet recruiting
    • Rectal Cancer
    • Chemoradiation treatment
    • 18FDG-PET/MRI scan
    • (no location specified)
    Sep 26, 2023

    Merkel Cell Carcinoma Trial in Milan (Retifanlimab, Cisplatin, Etoposide)

    Recruiting
    • Merkel Cell Carcinoma
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
    Jan 4, 2023

    Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

    Not yet recruiting
    • Pleural Mesothelioma
    • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
    • Rozzano, MI, Italy
    • +5 more
    Nov 30, 2023

    Dental Caries Trial in Damascus (Traditional Escavation, Excavation with Carisolv, Excavation with Sodium Hypochlorite Gel

    Not yet recruiting
    • Dental Caries
    • Traditional Escavation
    • +5 more
    • Damascus, Syrian Arab Republic
      Faculty of Dentistry, Damascus University
    Feb 8, 2023

    Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

    Recruiting
    • Ependymoma
    • +3 more
    • Augusta, Georgia
      Augusta University, Georgia Cancer Center
    Dec 16, 2022

    Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Jan 7, 2023

    Neuropathy;Peripheral Trial in Houston (Abbott® DRG / Abbott®/Medtronic® SCS, Control Group)

    Recruiting
    • Neuropathy;Peripheral
    • Abbott® DRG / Abbott®/Medtronic® SCS
    • Control Group
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 2, 2023

    Hepatocellular Carcinoma Portal Vein Thrombosis After

    Not yet recruiting
    • Hepatocellular Carcinoma
    • trans arterial chemoembolization
    • (no location specified)
    Aug 4, 2022

    Unresectable Intrahepatic Cholangiocarcinoma Trial in Baltimore (Durvalumab, SNDX-6352)

    Active, not recruiting
    • Unresectable Intrahepatic Cholangiocarcinoma
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Jan 10, 2023

    Nasopharyngeal Carcinoma, TNF, Chemo-radiotherapy Trial (5-fu, Cisplatin, Radiotherapy)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • +2 more
    • (no location specified)
    Jun 22, 2022

    Rectal Tumor Malignant Trial in GuangZhou (TME+LLND, TME+nCRT)

    Recruiting
    • Rectal Neoplasm Malignant
    • TME+LLND
    • TME+nCRT
    • GuangZhou, Guangdong, China
      The Sixth Affiliate Hospital of Sun Yat-Sen University
    Nov 22, 2022